Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 21.
doi: 10.1111/1346-8138.70017. Online ahead of print.

Decreased Plasmacytoid Dendritic Cells in Cutaneous Squamous Cell Carcinoma Arising From Subacute Cutaneous Lupus Erythematosus: A Case Report

Yao-Yu Lu  1 , Yu-Cheng Liu  2 , Yun-Wen Chiu  1 , Shiou-Fu Lin  3 , Yi-Hsien Shih  1   4
Affiliations

Decreased Plasmacytoid Dendritic Cells in Cutaneous Squamous Cell Carcinoma Arising From Subacute Cutaneous Lupus Erythematosus: A Case Report

Yao-Yu Lu et al. J Dermatol. .

Abstract

Patients with cutaneous lupus erythematosus (CLE) are highly susceptible to nonmelanoma skin cancers, including cutaneous squamous cell carcinoma (SCC). Despite the well-established involvement of plasmacytoid dendritic cells (pDCs) in CLE development, the exact role of pDCs in the pathogenesis of CLE-related SCC remains unclear. This report presents a case of SCC arising from a subacute cutaneous lupus erythematosus (SCLE) lesion. Histopathological examination revealed a notable decrease in CD123+ pDCs in the SCC lesion compared with that in the SCLE lesion in the same patient. pDCs may exert cytotoxic effects against cancer cells; thus, the absence of pDCs in the microenvironment of cutaneous SCC may facilitate immune evasion by cancer cells, thereby promoting tumor progression. These findings indicate the complex relationship between pDCs and cutaneous SCC development in patients with CLE. Future studies should clarify the role of pDCs in tumor surveillance and progression.

Keywords: cutaneous lupus erythematosus; cutaneous squamous cell carcinoma; plasmacytoid dendritic cells; skin cancer; subacute cutaneous lupus erythematosus.

PubMed Disclaimer

References

    1. H. Y. Schultz, J. P. Dutz, F. Furukawa, et al., “From Pathogenesis, Epidemiology, and Genetics to Definitions, Diagnosis, and Treatments of Cutaneous Lupus Erythematosus and Dermatomyositis: A Report From the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013,” Journal of Investigative Dermatology 135, no. 1 (2015): 7–12, https://doi.org/10.1038/jid.2014.316.
    1. C. M. Grönhagen, C. M. Fored, F. Granath, and F. Nyberg, “Increased Risk of Cancer Among 3663 Patients With Cutaneous Lupus Erythematosus: A Swedish Nationwide Cohort Study,” British Journal of Dermatology 166, no. 5 (2012): 1053–1059, https://doi.org/10.1111/j.1365‐2133.2011.10773.x.
    1. R. Westermann, K. Zobbe, R. Cordtz, J. H. Haugaard, and L. Dreyer, “Increased Cancer Risk in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus Compared With the General Population: A Danish Nationwide Cohort Study,” Lupus 30, no. 5 (2021): 752–761, https://doi.org/10.1177/0961203321990106.
    1. D. Saadeh, M. Kurban, and O. Abbas, “Plasmacytoid Dendritic Cell Role in Cutaneous Malignancies,” Journal of Dermatological Science 83, no. 1 (2016): 3–9, https://doi.org/10.1016/j.jdermsci.2016.05.008.
    1. W. Vermi, S. Lonardi, M. Morassi, et al., “Cutaneous Distribution of Plasmacytoid Dendritic Cells in Lupus Erythematosus. Selective Tropism at the Site of Epithelial Apoptotic Damage,” Immunobiology 214, no. 9–10 (2009): 877–886, https://doi.org/10.1016/j.imbio.2009.06.013.

LinkOut - more resources